Cleared Traditional

K172576 - BioHorizons Tapered Short Implants

K172576 is an FDA 510(k) clearance for BioHorizons Tapered Short Implants, manufactured by BioHorizons Implant Systems, Inc.. The device is a Class 2 Dental device with product code DZE cleared through the Traditional 510(k) pathway after a 86-day FDA review.

K172576 · BioHorizons Implant Systems, Inc. · Dental device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2017
Decision
86d
Days
Class 2
Risk

K172576 is an FDA 510(k) clearance for the BioHorizons Tapered Short Implants. Classified as Implant, Endosseous, Root-form (product code DZE), Class II - Special Controls.

Submitted by BioHorizons Implant Systems, Inc. (Birmingham, US). The FDA issued a Cleared decision on November 22, 2017 after a review of 86 days - a notably fast clearance cycle.

This device falls under the Dental FDA review panel, regulated under 21 CFR 872.3640 - the FDA dental device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all BioHorizons Implant Systems, Inc. devices

FDA 510(k) Submission Details - K172576

510(k) Number K172576 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 28, 2017
Decision Date November 22, 2017
Days to Decision 86 days
Submission Type Traditional
Review Panel Dental (DE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
41d faster than avg
Panel avg: 127d · This submission: 86d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DZE Device Classification - Class 2, Special Controls

Product Code DZE Implant, Endosseous, Root-form
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 872.3640
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Dental devices follow this clearance model.

Regulatory Peers - DZE Implant, Endosseous, Root-form

All 820
Devices cleared under the same product code (DZE) and FDA review panel - the closest regulatory comparables to K172576.
AR_N Type Implant System
K171297 · Biotem Co., Ltd. · Jan 2018
SPI Dental Implant System
K172240 · Msi France · Jan 2018
Straumann Dental Implant System
K171784 · Straumann USA, LLC · Jan 2018
External Hex Implants
K163634 · Southern Implants (Pty), Ltd. · Nov 2017
TREFOIL System
K172352 · Nobel Biocare AB · Oct 2017
Thommen Implant System
K171795 · Thommen Medical AG · Sep 2017